Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Authored Items
Rapid Biosimilar Adoption Possible in Community Oncology Practice
Chase Doyle
Web Exclusives
in
Biosimilars
,
ASCO Highlights
Delivering High-Value Personalized Interventions
Chase Doyle
Web Exclusives
in
Clinical Trials
Patients with Medicaid or No Insurance Have Worse Survival in Clinical Trials
Chase Doyle
Web Exclusives
in
Clinical Trials
Oral Parity Laws Could Reduce Disparities in Cancer Care
Chase Doyle
Web Exclusives
in
Disparities in Oncology
Patient-Centered Clinical Pathways Should Incorporate the Patient’s Voice
Chase Doyle
Web Exclusives
in
Clinical Trials
Financial Toxicity High for Low-Income Patients in Early-Phase Clinical Trials
Chase Doyle
Web Exclusives
Avelumab plus Axitinib New First-Line Standard of Care in Advanced Renal-Cell Carcinoma
Chase Doyle
Web Exclusives
in
Renal-Cell Carcinoma
Economic Implications of Inpatient versus Outpatient Autologous Transplant for Patients with Multiple Myeloma
Chase Doyle
Web Exclusives
in
Multiple Myeloma
CAR T-Cell Therapy Targeting Solid Tumors
Chase Doyle
Web Exclusives
in
Immunotherapy
CAR T-Cell Therapy Yields Impressive Responses in Aggressive Blood Cancer
Chase Doyle
Web Exclusives
in
Immunotherapy
First-in-Class Antibody-Drug Conjugate Effective in HER2-Negative Metastatic Breast Cancer
Chase Doyle
Web Exclusives
in
Breast Cancer
New Value Model Incorporates Long-Term Adverse Effects of Cancer Drugs
Chase Doyle
Web Exclusives
Programs Raise Awareness of Risks Associated with Testosterone Replacement Therapy
Chase Doyle
Web Exclusives
in
Genitourinary Cancers
Last modified: December 11, 2015